These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Was there really any evidence that rosiglitazone increased the risk of myocardial infarction or death from cardiovascular causes? Stone JC; Furuya-Kanamori L; Barendregt JJ; Doi SA Pharmacoepidemiol Drug Saf; 2015 Mar; 24(3):223-7. PubMed ID: 25515780 [TBL] [Abstract][Full Text] [Related]
38. Drug safety. Heart attack risk overshadows a popular diabetes therapy. Couzin J Science; 2007 Jun; 316(5831):1550-1. PubMed ID: 17569830 [No Abstract] [Full Text] [Related]
39. FDA eases restrictions on the glucose-lowering drug rosiglitazone. Mitka M JAMA; 2013 Dec; 310(24):2604. PubMed ID: 24368444 [No Abstract] [Full Text] [Related]
40. Rosiglitazone: opening Pandora's black box? Gilbert RE Clin J Am Soc Nephrol; 2007 Nov; 2(6):1329-31. PubMed ID: 17928463 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]